UM Ventures News
Commercial Success: UMB Researcher-Developed BCRP Patent Portfolio Licensed Three Times in 2013
Wednesday, February 5, 2014
Rexahn Initiates Phase Ib Clinical Trial of RX-3117 for Treatment of Solid Tumors
Thursday, January 23, 2014
Bioentrepreneurship Leader Joins UM Ventures Team
Friday, January 10, 2014
Three Companies with UMB Roots Make Progress in Late 2013
Thursday, December 19, 2013
Jim Hughes and UM Ventures Featured on BioBuzz
Saturday, November 30, 2013
New IBBR Director Envisions Premier Biotechnology Research Institute
Monday, November 25, 2013
Alba Therapeutics Names New CEO
Monday, November 4, 2013
Nobel Laureate Comes to Campus to Share His Love of Science
Sunday, November 3, 2013